Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4852799
Max Phase: Preclinical
Molecular Formula: C56H79N19O11
Molecular Weight: 1194.37
Molecule Type: Unknown
Associated Items:
ID: ALA4852799
Max Phase: Preclinical
Molecular Formula: C56H79N19O11
Molecular Weight: 1194.37
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@@H]1NC(=O)CCC(=O)NCCCCNC(=O)NC(=N)NCCC[C@@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC1=O
Standard InChI: InChI=1S/C56H79N19O11/c57-47(80)42(28-32-13-17-35(76)18-14-32)72-49(82)40(11-6-26-65-54(60)61)71-52(85)44(30-34-31-68-38-9-2-1-8-37(34)38)74-50(83)41-12-7-27-66-55(62)75-56(86)67-24-4-3-23-63-45(78)21-22-46(79)69-39(10-5-25-64-53(58)59)48(81)73-43(51(84)70-41)29-33-15-19-36(77)20-16-33/h1-2,8-9,13-20,31,39-44,68,76-77H,3-7,10-12,21-30H2,(H2,57,80)(H,63,78)(H,69,79)(H,70,84)(H,71,85)(H,72,82)(H,73,81)(H,74,83)(H4,58,59,64)(H4,60,61,65)(H4,62,66,67,75,86)/t39-,40-,41-,42-,43-,44-/m0/s1
Standard InChI Key: WBAUBHSESZYDCK-WGXSSYHUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1194.37 | Molecular Weight (Monoisotopic): 1193.6206 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Konieczny A, Conrad M, Ertl FJ, Gleixner J, Gattor AO, Grätz L, Schmidt MF, Neu E, Horn AHC, Wifling D, Gmeiner P, Clark T, Sticht H, Keller M.. (2021) N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y4 Receptor Ligands Results in Picomolar Binding Constants., 64 (22.0): [PMID:34748345] [10.1021/acs.jmedchem.1c01574] |
Source(1):